- Published on
Emergency And Acute Medicine – Rubella
Rubella, also known as German measles or “3-day measles,” is an acute viral illness transmitted via respiratory droplets. It is moderately contagious, particularly during the period surrounding rash onset. Patients are infectious from approximately 7 days before to 5 days after the appearance of the rash. The incubation period ranges from 14 to 21 days. Up to 50% of infections may be subclinical. Infants with congenital rubella syndrome (CRS) are especially important reservoirs, as they can shed large amounts of virus for months after birth.
The disease is caused by the rubella virus, a member of the Togaviridae family (genus Rubivirus). Vaccination with the live attenuated measles–mumps–rubella (MMR) vaccine is highly effective and is recommended for all children older than 12 months, as well as women of childbearing age who are not immune. A single dose typically provides lifelong protection.
Clinically, rubella is usually a mild, self-limited illness. Patients often present with low-grade fever, malaise, headache, and mild upper respiratory symptoms. The characteristic rash begins on the face and spreads rapidly downward (cephalocaudal spread), usually completing its spread within 24 hours. The rash consists of faint red macules that evolve into pink-red maculopapules, often with mild itching, and typically resolves within 3 days without coalescing—unlike measles. A key distinguishing feature is prominent lymphadenopathy, especially involving the postauricular, occipital, and posterior cervical lymph nodes.
Complications are generally uncommon but occur more frequently in adults. Arthritis is the most common complication, particularly in women (up to 79%), affecting joints such as the knees, wrists, and fingers; it typically begins a few days after illness onset and is usually self-limited. Hemorrhagic complications due to thrombocytopenia are more common in children. Neurologic complications, including encephalitis, are rare but can occur, particularly in adults, and generally have a good prognosis.
The most serious consequence of rubella infection is congenital rubella syndrome (CRS), which occurs when a pregnant woman—especially during the first trimester—is infected. CRS can lead to severe fetal abnormalities, including hearing loss, intellectual disability, congenital heart defects, and ocular abnormalities. Because of this, rubella is a major public health concern despite its typically mild presentation in children.
Diagnosis is often clinical, based on the characteristic rash and lymphadenopathy. Laboratory confirmation can be obtained with rubella-specific IgM antibodies (detectable about 4 days after rash onset) or by demonstrating a rise in antibody titers between acute and convalescent samples. Reverse transcriptase PCR may also detect viral RNA. Laboratory findings may include leukopenia and thrombocytopenia, particularly in children. Testing is especially important in pregnant women with suspected exposure.
The differential diagnosis includes measles (which presents with higher fever, cough, coryza, conjunctivitis, and Koplik spots), scarlet fever (with a “sandpaper” rash and strawberry tongue), roseola (rash after fever resolution), Rocky Mountain spotted fever (rash beginning at wrists and ankles), and other viral exanthems.
Management is primarily supportive. Treatment includes rest, hydration, and symptomatic relief with antipyretics such as acetaminophen or ibuprofen. There is no specific antiviral therapy. Patients should be isolated from susceptible individuals—especially pregnant women and immunocompromised persons—for at least 7 days after rash onset.
Prevention through vaccination is critical. The MMR vaccine is indicated for children older than 12 months, unimmunized individuals, healthcare workers, and women of childbearing age who are not pregnant. Vaccination is contraindicated during pregnancy, and women are advised to avoid pregnancy for at least 3 months after receiving the vaccine. Immunoglobulin may be considered after exposure in certain high-risk individuals, but it does not prevent infection and only modifies disease severity.
Most patients can be managed as outpatients. Hospital admission is reserved for severe complications such as encephalitis or CRS. Pregnant women with suspected exposure or infection require close follow-up, serologic monitoring, and obstetric consultation.
A key clinical pearl is the importance of recognizing rubella due to its implications for pregnancy. Additionally, current evidence does not support any causal link between rubella vaccination and autism spectrum disorders.
0 Comments
